649 related articles for article (PubMed ID: 35272024)
21.
Huang S; Zhao N; Qian Z; Yuan W
J Mater Chem B; 2023 Apr; 11(16):3727-3739. PubMed ID: 37067286
[TBL] [Abstract][Full Text] [Related]
22. Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers.
Sun CY; Cao Z; Zhang XJ; Sun R; Yu CS; Yang X
Theranostics; 2018; 8(11):2939-2953. PubMed ID: 29896295
[TBL] [Abstract][Full Text] [Related]
23. Folic acid-modified bovine serum albumin nanoparticles with doxorubicin and chlorin e6 for effective combinational chemo-photodynamic therapy.
Lee H; Kim S; Oh C; Khan I; Shukla S; Bajpai VK; Han YK; Huh YS
Mater Sci Eng C Mater Biol Appl; 2020 Dec; 117():111343. PubMed ID: 32919690
[TBL] [Abstract][Full Text] [Related]
24. Zwitterionic Reduction-Activated Supramolecular Prodrug Nanocarriers for Photodynamic Ablation of Cancer Cells.
Zhao Y; Deng Y; Tang Z; Jin Q; Ji J
Langmuir; 2019 Feb; 35(5):1919-1926. PubMed ID: 30204452
[TBL] [Abstract][Full Text] [Related]
25. Targeted delivery and enhanced uptake of chemo-photodynamic nanomedicine for melanoma treatment.
Huang X; Mu N; Ding Y; Lam HW; Yue L; Gao C; Chen T; Yuan Z; Wang R
Acta Biomater; 2022 Jul; 147():356-365. PubMed ID: 35577046
[TBL] [Abstract][Full Text] [Related]
26. Enzyme and pH dual-responsive hyaluronic acid nanoparticles mediated combination of photodynamic therapy and chemotherapy.
Ren Q; Liang Z; Jiang X; Gong P; Zhou L; Sun Z; Xiang J; Xu Z; Peng X; Li S; Li W; Cai L; Tang J
Int J Biol Macromol; 2019 Jun; 130():845-852. PubMed ID: 30844454
[TBL] [Abstract][Full Text] [Related]
27. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P
ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750
[TBL] [Abstract][Full Text] [Related]
28.
Dong Y; Du P; Liu P
Int J Pharm; 2020 Oct; 588():119723. PubMed ID: 32755688
[TBL] [Abstract][Full Text] [Related]
29. Highly-controllable drug release from core cross-linked singlet oxygen-responsive nanoparticles for cancer therapy.
Zhou J; Sun C; Yu C
RSC Adv; 2020 May; 10(34):19997-20008. PubMed ID: 35520443
[TBL] [Abstract][Full Text] [Related]
30. A Redox-Activatable and Targeted Photosensitizing Agent to Deliver Doxorubicin for Combining Chemotherapy and Photodynamic Therapy.
Yin J; Ouyang C; Shen S; Zhou Y; He G; Zhang H; Zhou K; Chen G; Ren L
Mol Pharm; 2022 Jul; 19(7):2441-2455. PubMed ID: 35616274
[TBL] [Abstract][Full Text] [Related]
31. Non-interference delivery of Ce6 and DOX in NIR light-responsive liposomes for synergetic cervical cancer therapy.
Zhang J; Yang Y; Gao Y; Bai Z; Zhang X; Li K; Liu Z; Shi M; Zhao Y; Wang J; Li J
Biomed Mater; 2023 Jul; 18(5):. PubMed ID: 37406639
[TBL] [Abstract][Full Text] [Related]
32. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
33. Surface Charge Switchable Supramolecular Nanocarriers for Nitric Oxide Synergistic Photodynamic Eradication of Biofilms.
Hu D; Deng Y; Jia F; Jin Q; Ji J
ACS Nano; 2020 Jan; 14(1):347-359. PubMed ID: 31887012
[TBL] [Abstract][Full Text] [Related]
34. Chitosan oligosaccharide-functionalized nano-prodrug for cascade chemotherapy through oxidative stress amplification.
Cui L; Xu Q; Lou W; Wang Y; Xi X; Chen Y; Sun M; Wang Z; Zhang P; Yang S; Zhang L; Qu L
Int J Biol Macromol; 2024 May; 268(Pt 2):131641. PubMed ID: 38641277
[TBL] [Abstract][Full Text] [Related]
35. Doxorubicin-loaded pH-responsive nanoparticles coated with chlorin e6 for drug delivery and synergetic chemo-photodynamic therapy.
Liang J; Jin X; Chen B; Hu J; Huang Q; Wan J; Hu Z; Wang B
Nanotechnology; 2020 May; 31(19):195103. PubMed ID: 31978912
[TBL] [Abstract][Full Text] [Related]
36. On-demand PEGylation and dePEGylation of PLA-based nanocarriers
Zhu Y; Chen C; Cao Z; Shen S; Li L; Li D; Wang J; Yang X
Theranostics; 2019; 9(26):8312-8320. PubMed ID: 31754398
[No Abstract] [Full Text] [Related]
37. NO-releasing polypeptide nanocomposites reverse cancer multidrug resistance via triple therapies.
Ding Y; Ma Y; Du C; Wang C; Chen T; Wang Y; Wang J; Yao Y; Dong CM
Acta Biomater; 2021 Mar; 123():335-345. PubMed ID: 33476826
[TBL] [Abstract][Full Text] [Related]
38. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
[TBL] [Abstract][Full Text] [Related]
39. Disulfide-Bridged Dendritic Organosilicas-Based Biodegradable Molecularly Imprinted Polymers for Multiple Targeting and pH/Redox-Responsive Drug Release toward Chemical/Photodynamic Synergistic Tumor Therapy.
Liu S; Han S; Song Y; Sun R; Zhao L; Yan C
Adv Healthc Mater; 2023 Aug; 12(20):e2300184. PubMed ID: 36943098
[TBL] [Abstract][Full Text] [Related]
40. A pH-Responsive Charge-Reversal Drug Delivery System with Tumor-Specific Drug Release and ROS Generation for Cancer Therapy.
Xu C; Song R; Lu P; Chen J; Zhou Y; Shen G; Jiang M; Zhang W
Int J Nanomedicine; 2020; 15():65-80. PubMed ID: 32021165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
